ES2163000T3 - Suministro topico de farmacos al tracto gastrointestinal inferior. - Google Patents

Suministro topico de farmacos al tracto gastrointestinal inferior.

Info

Publication number
ES2163000T3
ES2163000T3 ES96903489T ES96903489T ES2163000T3 ES 2163000 T3 ES2163000 T3 ES 2163000T3 ES 96903489 T ES96903489 T ES 96903489T ES 96903489 T ES96903489 T ES 96903489T ES 2163000 T3 ES2163000 T3 ES 2163000T3
Authority
ES
Spain
Prior art keywords
pharmacos
gastrointestinal tract
lower gastrointestinal
colon
dosage form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96903489T
Other languages
English (en)
Inventor
David L Berliner
Sergio Nacht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heron Therapeutics LLC
Original Assignee
Advanced Polymer Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Polymer Systems Inc filed Critical Advanced Polymer Systems Inc
Application granted granted Critical
Publication of ES2163000T3 publication Critical patent/ES2163000T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin

Abstract

TRATAMIENTO DE DETERMINADAS ENFERMEDADES DEL COLON MEDIANTE LA INGESTION ORAL EN UNA FORMA DE DOSIFICACION ADECUADA QUE CONTIENE UNA COMPOSICION QUE CONTIENE UNA VARIEDAD DE CUENTAS DE POLIMERO RIGIDAS RETICULADAS, DEFINIENDO CADA UNA RED DE POROS INTERNOS SUSTANCIALMENTE NO COLAPSABLE, Y UNA CANTIDAD TERAPEUTICAMENTE EFICAZ DE UN AGENTE O FARMACO ACTIVO EN DICHA RED DE POROS. LA FORMA DE DOSIFICACION SE TRATA CON UN POLISACARIDO TAL COMO PECTINA, QUE ES ESPECIFICAMENTE ATACADA POR LA FLORA BACTERIANA PARA PERMITIR LA LIBERACION DEL FARMACO EN EL COLON.
ES96903489T 1996-01-16 1996-01-16 Suministro topico de farmacos al tracto gastrointestinal inferior. Expired - Lifetime ES2163000T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/000512 WO1997025980A1 (en) 1996-01-16 1996-01-16 Topical delivery of drugs to the lower gastrointestinal tract

Publications (1)

Publication Number Publication Date
ES2163000T3 true ES2163000T3 (es) 2002-01-16

Family

ID=22254620

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96903489T Expired - Lifetime ES2163000T3 (es) 1996-01-16 1996-01-16 Suministro topico de farmacos al tracto gastrointestinal inferior.

Country Status (9)

Country Link
EP (1) EP0876142B1 (es)
KR (1) KR19990077278A (es)
AT (1) ATE206043T1 (es)
AU (1) AU710109B2 (es)
CA (1) CA2244421A1 (es)
DE (1) DE69615583T2 (es)
DK (1) DK0876142T3 (es)
ES (1) ES2163000T3 (es)
WO (1) WO1997025980A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972933A (en) * 1998-01-08 1999-10-26 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of treating microbial infections
US7022683B1 (en) * 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
IL124957A0 (en) * 1998-06-16 1999-01-26 Univ Ben Gurion Active ingredient delivery systems and devices based on porous matrices
IT1301947B1 (it) * 1998-07-28 2000-07-20 Chiesi Farma Spa Formulazioni farmaceutiche di beclometasone dipropionato per iltrattamento di malattie infiammatorie croniche della mucosa
ES2197600T3 (es) 1999-01-29 2004-01-01 Disphar International B.V. Composiciones farmaceuticas.
US20020004502A1 (en) 2000-01-05 2002-01-10 Redmond H. Paul Treatment of inflammatory bowel disease
US7045589B2 (en) 2002-11-15 2006-05-16 A.P. Pharma, Inc. Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them
EP2380564B1 (en) 2007-04-04 2014-10-22 Sigmoid Pharma Limited An oral pharmaceutical composition
CZ302789B6 (cs) 2009-11-25 2011-11-09 Zentiva, K. S. Zpusob zvýšení rozpustnosti farmaceuticky aktivních látek a cílený (kontrolovaný) transport do streva
IT1405012B1 (it) * 2010-08-06 2013-12-16 Sofar Spa Composizioni di beclometasone dipropionato in microsfere gastroresistenti a rilascio modificato e processo per il loro ottenimento
GB201119985D0 (en) * 2011-11-19 2012-01-04 Diurnal Ltd Treatment of adrenal insufficiency
GB201202433D0 (en) 2012-02-13 2012-03-28 Diurnal Ltd Controlled drug release
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
GB201308933D0 (en) 2013-05-17 2013-07-03 Diurnal Ltd Paediatric composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD291668A7 (de) * 1986-02-28 1991-07-11 Berlin-Chemie Ag,De Verfahren zur herstellung einer oral anwendbaren gnrh-zubereitung
CA2082156A1 (en) * 1990-05-04 1991-11-05 Amnon Sintov Colonic drug delivery system
AU8050791A (en) * 1990-06-20 1992-01-07 Advanced Polymer Systems Inc. Compositions and methods for the controlled release of soluble active substances

Also Published As

Publication number Publication date
AU4756496A (en) 1997-08-11
ATE206043T1 (de) 2001-10-15
EP0876142B1 (en) 2001-09-26
DE69615583T2 (de) 2002-07-11
AU710109B2 (en) 1999-09-16
DE69615583D1 (de) 2001-10-31
DK0876142T3 (da) 2001-11-19
EP0876142A1 (en) 1998-11-11
WO1997025980A1 (en) 1997-07-24
KR19990077278A (ko) 1999-10-25
CA2244421A1 (en) 1997-07-24

Similar Documents

Publication Publication Date Title
ES2163000T3 (es) Suministro topico de farmacos al tracto gastrointestinal inferior.
PT1079806E (pt) Preparacoes para a aplicacao de anti-inflamatorios, especialmente, agentes anti-septicos e/ou agentes de promocao da cura de feridas, no tracto respiratorio superior e/ou no ouvido
DE69826644D1 (de) Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
HUP9900950A2 (hu) Nikotin-származékok alkalmazása gyulladásos bélbetegségek kezelésére alkalmas gyógyászati készítmények előállítására
ES2196556T3 (es) Formulacion en granulos para el tratamiento del tracto intestinal.
BR9814378A (pt) Forma de dosagem de liberação prolongada farmacêutica revestida entérica de um inibidor de h+, k+-atpase, processos para a manufatura da mesma, para melhorar a inibição de secreção de ácido gástrico, para melhorar o efeito terapêutico no tratamento de distúrbios gastrointentinais, para receber um perfil de plasma prolongado de um inibidor da h+, k+-atpase, e, usos de uma composição farmacêutica e de inibidor da h+, k+-atpase
AU2002231889A1 (en) Halogenated composition, method for preparing same and uses thereof
RU2004138807A (ru) Новые сложные эфиры этоногестрела
JP2008503445A5 (es)
CA2383212A1 (en) Controlled release oral dosage suitable for oral administration
BR9709316A (pt) Composição farmacêutica para administração tópica no tratamento da vaginite
FR2784897B1 (fr) Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux
ATE253369T1 (de) Phosphatidylcholin als arzneimittel mit schleimhautschützender wirkung
CA2234936A1 (en) Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
ATE415964T1 (de) Abführzusammensetzung,welche l-arginine enthält
CA2472449A1 (en) Pharmaceutical composition for oral use with improved absorption
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
SE9700617D0 (sv) New composition
RU2004101641A (ru) Способ лечения красного плоского лишая
RU2150271C1 (ru) Способ лечения хронического гастрита, язвенной болезни желудка и двенадцатиперстной кишки
JP2006503049A5 (es)
RU2120293C1 (ru) Противовоспалительное средство
MA23429A1 (fr) Novelle forme galenique de derives de 5-nitro imidazole efficace pour le traitement des parasitoses et des infections de l'ensemble du tractus-gastro-intestinal.
RU96112456A (ru) Способ лечения бактериального вагиноза и воспалительных процессов гениталий
Bull Mafenide acetate (sulfamylon) and silver sulphadiazine creams for local treatment of burns

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 876142

Country of ref document: ES